ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global and India Biopharmaceuticals Market Report & Forecast 2023-2029
Published Date: November 2023
|
Report Code: QYRE-Auto-5Z15867
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global and India Biopharmaceuticals Market Report Forecast 2023 2029
BUY CHAPTERS

Global and India Biopharmaceuticals Market Report & Forecast 2023-2029

Code: QYRE-Auto-5Z15867
Report
November 2023
Pages:116
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Roche
Amgen Inc
AbbVie
Sanofi Aventis
Johnson & Johnson
Pfizer Inc
Novo Nordisk
Eli Lilly
Novartis
Merck
Sun
3SBio Inc
Changchun High Tech
CP Guojian
Biotech
Gelgen
Innovent
Dong Bao
Ganlee
United Laboratories
Sandoz(Novartis)
Teva Pharmaceutical
Hospira (Pfizer)
Mylan NV
Sun Pharma

and India Biopharmaceuticals Market Size

The global Biopharmaceuticals revenue was US$ 32400 million in 2022 and is forecast to a readjusted size of US$ 55880 million by 2029 with a CAGR of 8.0% during the review period (2023-2029).

and India Biopharmaceuticals Market

and India Biopharmaceuticals Market

A biopharmaceutical, also known as a biologic (al) medical product, biological, or biologic, is any pharmaceutical drug product manufactured in, extracted from, or semi synthesized from biological sources. Different from totally synthesized pharmaceuticals, they include vaccines, blood, blood components, allergenic, somatic cells, gene therapies, tissues, recombinant therapeutic protein, and living cells used in cell therapy. Biologics can be composed of sugars, proteins, or nucleic acids or complex combinations of these substances, or may be living cells or tissues. They (or their precursors or components) are isolated from living sources—human, animal, plant, fungal, or microbial.
In India, the Biopharmaceuticals revenue is expected to grow from US$ million in 2022 to US$ million by 2029, at a CAGR of % during the forecast period 2023-2029.
The global key players of Biopharmaceuticals include Roche, Amgen, AbbVie, Sanofi-Aventis, Johnson & Johnson, Pfizer, Novo Nordisk, Eli Lilly and Novartis, etc. The global five biggest players hold a share of % in 2022.
This report focuses on global and India Biopharmaceuticals market, also covers the segmentation data of other regions in regional level and county level.
India is now the world’s most populous country. According to IMF (its July update to its World Economic Outlook), India’s GDP growth is projected at 6.1% in 2023, powered by domestic investment. First and foremost, the key factor in India's rapid economic growth is the huge supply and demand from a large population base. Demand and supply sides working in both directions to support India's economic stability.
India is a market full of opportunities, and the demand for Biopharmaceuticals will continue to grow rapidly in the future.
Global Biopharmaceuticals Scope and Market Size
Biopharmaceuticals market is segmented in regional and country level, by players, by Type and by Application. Companies, stakeholders, and other participants in the global Biopharmaceuticals market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2018-2029.
For India market, this report focuses on the Biopharmaceuticals market size by players, by Type and by Application, for the period 2018-2029. The key players include the global and local players, which play important roles in India.

Scope of and India Biopharmaceuticals Market Report

Report Metric Details
Report Name and India Biopharmaceuticals Market
Forecasted market size in 2029 US$ 55880 million
CAGR 8.0%
Forecasted years 2023 - 2029
Segment by Type
  • Monoclonal Antibodies
  • Interferon
  • Colony-Stimulating Factor
  • Erythropoietin
  • Insulin
  • Vaccines
  • Growth Hormones
  • Others
Segment by Application
  • Tumor
  • Diabetes
  • Cardiovascular
  • Hemophilia
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Roche, Amgen, AbbVie, Sanofi-Aventis, Johnson & Johnson, Pfizer, Novo Nordisk, Eli Lilly, Novartis, Merck, Sun, 3sbio, Changchun High Tech, CP Guojian, Biotech, Gelgen, Innovent, Dong Bao, Ganlee, United Laboratories, SANDOZ (NOVARTIS), Teva Pharmaceutical, Hospira （Pfizer）, MYLAN, Sun pharma
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

FAQ for this report

What is the and India Biopharmaceuticals Market size in 2029?

Ans: The and India Biopharmaceuticals Market size in 2029 will be US$ 55880 million.

What is the and India Biopharmaceuticals Market share by region?

Ans: According to IMF (its July update to its World Economic Outlook), India’s GDP growth is projected at 6.1% in 2023, powered by domestic investment.

Who are the main players in the and India Biopharmaceuticals Market report?

Ans: The main players in the and India Biopharmaceuticals Market are Roche, Amgen, AbbVie, Sanofi-Aventis, Johnson & Johnson, Pfizer, Novo Nordisk, Eli Lilly, Novartis, Merck, Sun, 3sbio, Changchun High Tech, CP Guojian, Biotech, Gelgen, Innovent, Dong Bao, Ganlee, United Laboratories, SANDOZ (NOVARTIS), Teva Pharmaceutical, Hospira （Pfizer）, MYLAN, Sun pharma

What are the Application segmentation covered in the and India Biopharmaceuticals Market report?

Ans: The Applications covered in the and India Biopharmaceuticals Market report are Tumor, Diabetes, Cardiovascular, Hemophilia, Others

What are the Type segmentation covered in the and India Biopharmaceuticals Market report?

Ans: The Types covered in the and India Biopharmaceuticals Market report are Monoclonal Antibodies, Interferon, Colony-Stimulating Factor, Erythropoietin, Insulin, Vaccines, Growth Hormones, Others

1 Study Coverage
1.1 Biopharmaceuticals Product Introduction
1.2 Global Biopharmaceuticals Outlook 2018 VS 2022 VS 2029
1.2.1 Global Biopharmaceuticals Market Size for the Year 2018-2029
1.2.2 India Biopharmaceuticals Market Size for the Year 2018-2029
1.3 Biopharmaceuticals Market Size, India VS Global, 2018 VS 2022 VS 2029
1.3.1 The Market Share of India Biopharmaceuticals in Global, 2018 VS 2022 VS 2029
1.3.2 The Growth Rate of Biopharmaceuticals Market Size, India VS Global, 2018 VS 2022 VS 2029
1.4 Biopharmaceuticals Market Dynamics
1.4.1 Biopharmaceuticals Industry Trends
1.4.2 Biopharmaceuticals Market Drivers
1.4.3 Biopharmaceuticals Market Challenges
1.4.4 Biopharmaceuticals Market Restraints
1.5 Assumptions and Limitations
1.6 Study Objectives
1.7 Years Considered
2 Biopharmaceuticals by Type
2.1 Biopharmaceuticals Market Segment by Type
2.1.1 Monoclonal Antibodies
2.1.2 Interferon
2.1.3 Colony-Stimulating Factor
2.1.4 Erythropoietin
2.1.5 Insulin
2.1.6 Vaccines
2.1.7 Growth Hormones
2.1.8 Others
2.2 Global Biopharmaceuticals Market Size by Type (2018, 2022 & 2029)
2.3 Global Biopharmaceuticals Market Size by Type (2018-2029)
2.4 India Biopharmaceuticals Market Size by Type (2018, 2022 & 2029)
2.5 India Biopharmaceuticals Market Size by Type (2018-2029)
3 Biopharmaceuticals by Application
3.1 Biopharmaceuticals Market Segment by Application
3.1.1 Tumor
3.1.2 Diabetes
3.1.3 Cardiovascular
3.1.4 Hemophilia
3.1.5 Others
3.2 Global Biopharmaceuticals Market Size by Application (2018, 2022 & 2029)
3.3 Global Biopharmaceuticals Market Size by Application (2018-2029)
3.4 India Biopharmaceuticals Market Size by Application (2018, 2022 & 2029)
3.5 India Biopharmaceuticals Market Size by Application (2018-2029)
4 Global Biopharmaceuticals Competitor Landscape by Company
4.1 Global Biopharmaceuticals Market Size by Company
4.1.1 Global Key Companies of Biopharmaceuticals, Ranked by Revenue (2022)
4.1.2 Global Biopharmaceuticals Revenue by Player (2018-2023)
4.2 Global Biopharmaceuticals Concentration Ratio (CR)
4.2.1 Biopharmaceuticals Market Concentration Ratio (CR) (2018-2023)
4.2.2 Global Top 5 and Top 10 Largest Companies of Biopharmaceuticals in 2022
4.2.3 Global Biopharmaceuticals Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Key Players of Biopharmaceuticals Head office and Area Served
4.4 Global Key Players of Biopharmaceuticals, Product and Application
4.5 Global Key Players of Biopharmaceuticals, Date of Enter into This Industry
4.6 Companies Mergers & Acquisitions, Expansion Plans
4.7 India Biopharmaceuticals Market Size by Company
4.7.1 Key Players of Biopharmaceuticals in India, Ranked by Revenue (2022)
4.7.2 India Biopharmaceuticals Revenue by Players (2021, 2022 & 2023)
5 Global Biopharmaceuticals Market Size by Region
5.1 Global Biopharmaceuticals Market Size by Region: 2018 VS 2022 VS 2029
5.2 Global Biopharmaceuticals Market Size by Region (2018-2029)
5.2.1 Global Biopharmaceuticals Market Size by Region: 2018-2023
5.2.2 Global Biopharmaceuticals Market Size by Region (2024-2029)
6 Americas
6.1 Americas Biopharmaceuticals Market Size YoY Growth 2018-2029
6.2 Americas Biopharmaceuticals Market Size by Type
6.2.1 Americas Biopharmaceuticals Market Size by Type (2018-2023)
6.2.2 Americas Biopharmaceuticals Market Size by Type (2024-2029)
6.2.3 Americas Biopharmaceuticals Market Share by Type (2018-2029)
6.3 Americas Biopharmaceuticals Market Size by Application
6.3.1 Americas Biopharmaceuticals Market Size by Application (2018-2023)
6.3.2 Americas Biopharmaceuticals Market Size by Application (2024-2029)
6.3.3 Americas Biopharmaceuticals Market Share by Application (2018-2029)
6.4 Americas Biopharmaceuticals Market Facts & Figures by Country (2018, 2022 & 2029)
6.4.1 United States
6.4.2 Canada
6.4.3 Mexico
6.4.4 Brazil
7 EMEA
7.1 EMEA Biopharmaceuticals Market Size YoY Growth 2018-2029
7.2 EMEA Biopharmaceuticals Market Size by Type
7.2.1 EMEA Biopharmaceuticals Market Size by Type (2018-2023)
7.2.2 EMEA Biopharmaceuticals Market Size by Type (2024-2029)
7.2.3 EMEA Biopharmaceuticals Market Share by Type (2018-2029)
7.3 EMEA Biopharmaceuticals Market Size by Application
7.3.1 EMEA Biopharmaceuticals Market Size by Application (2018-2023)
7.3.2 EMEA Biopharmaceuticals Market Size by Application (2024-2029)
7.3.3 EMEA Biopharmaceuticals Market Share by Application (2018-2029)
7.4 EMEA Biopharmaceuticals Market Facts & Figures by Country (2018, 2022 & 2029)
7.4.1 Europe
7.4.2 Middle East
7.4.3 Africa
8 China
8.1 China Biopharmaceuticals Market Size YoY Growth 2018-2029
8.2 China Biopharmaceuticals Market Size by Type
8.2.1 China Biopharmaceuticals Market Size by Type (2018-2023)
8.2.2 China Biopharmaceuticals Market Size by Type (2024-2029)
8.2.3 China Biopharmaceuticals Market Share by Type (2018-2029)
8.3 China Biopharmaceuticals Market Size by Application
8.3.1 China Biopharmaceuticals Market Size by Application (2018-2023)
8.3.2 China Biopharmaceuticals Market Size by Application (2024-2029)
8.3.3 China Biopharmaceuticals Market Share by Application (2018-2029)
9 APAC (excluding China)
9.1 APAC Biopharmaceuticals Market Size YoY Growth 2018-2029
9.2 APAC Biopharmaceuticals Market Size by Type
9.2.1 APAC Biopharmaceuticals Market Size by Type (2018-2023)
9.2.2 APAC Biopharmaceuticals Market Size by Type (2024-2029)
9.2.3 APAC Biopharmaceuticals Market Share by Type (2018-2029)
9.3 APAC Biopharmaceuticals Market Size by Application
9.3.1 APAC Biopharmaceuticals Market Size by Application (2018-2023)
9.3.2 APAC Biopharmaceuticals Market Size by Application (2024-2029)
9.3.3 APAC Biopharmaceuticals Market Share by Application (2018-2029)
9.4 APAC Biopharmaceuticals Market Facts & Figures by Country (2018, 2022 & 2029)
9.4.1 Japan
9.4.2 South Korea
9.4.3 China Taiwan
9.4.4 Southeast Asia
9.4.5 India
10 Key Players Profiles
10.1 Roche
10.1.1 Roche Company Details
10.1.2 Roche Business Overview
10.1.3 Roche Biopharmaceuticals Introduction
10.1.4 Roche Revenue in Biopharmaceuticals Business (2018-2023)
10.1.5 Roche Recent Development
10.2 Amgen
10.2.1 Amgen Company Details
10.2.2 Amgen Business Overview
10.2.3 Amgen Biopharmaceuticals Introduction
10.2.4 Amgen Revenue in Biopharmaceuticals Business (2018-2023)
10.2.5 Amgen Recent Development
10.3 AbbVie
10.3.1 AbbVie Company Details
10.3.2 AbbVie Business Overview
10.3.3 AbbVie Biopharmaceuticals Introduction
10.3.4 AbbVie Revenue in Biopharmaceuticals Business (2018-2023)
10.3.5 AbbVie Recent Development
10.4 Sanofi-Aventis
10.4.1 Sanofi-Aventis Company Details
10.4.2 Sanofi-Aventis Business Overview
10.4.3 Sanofi-Aventis Biopharmaceuticals Introduction
10.4.4 Sanofi-Aventis Revenue in Biopharmaceuticals Business (2018-2023)
10.4.5 Sanofi-Aventis Recent Development
10.5 Johnson & Johnson
10.5.1 Johnson & Johnson Company Details
10.5.2 Johnson & Johnson Business Overview
10.5.3 Johnson & Johnson Biopharmaceuticals Introduction
10.5.4 Johnson & Johnson Revenue in Biopharmaceuticals Business (2018-2023)
10.5.5 Johnson & Johnson Recent Development
10.6 Pfizer
10.6.1 Pfizer Company Details
10.6.2 Pfizer Business Overview
10.6.3 Pfizer Biopharmaceuticals Introduction
10.6.4 Pfizer Revenue in Biopharmaceuticals Business (2018-2023)
10.6.5 Pfizer Recent Development
10.7 Novo Nordisk
10.7.1 Novo Nordisk Company Details
10.7.2 Novo Nordisk Business Overview
10.7.3 Novo Nordisk Biopharmaceuticals Introduction
10.7.4 Novo Nordisk Revenue in Biopharmaceuticals Business (2018-2023)
10.7.5 Novo Nordisk Recent Development
10.8 Eli Lilly
10.8.1 Eli Lilly Company Details
10.8.2 Eli Lilly Business Overview
10.8.3 Eli Lilly Biopharmaceuticals Introduction
10.8.4 Eli Lilly Revenue in Biopharmaceuticals Business (2018-2023)
10.8.5 Eli Lilly Recent Development
10.9 Novartis
10.9.1 Novartis Company Details
10.9.2 Novartis Business Overview
10.9.3 Novartis Biopharmaceuticals Introduction
10.9.4 Novartis Revenue in Biopharmaceuticals Business (2018-2023)
10.9.5 Novartis Recent Development
10.10 Merck
10.10.1 Merck Company Details
10.10.2 Merck Business Overview
10.10.3 Merck Biopharmaceuticals Introduction
10.10.4 Merck Revenue in Biopharmaceuticals Business (2018-2023)
10.10.5 Merck Recent Development
10.11 Sun
10.11.1 Sun Company Details
10.11.2 Sun Business Overview
10.11.3 Sun Biopharmaceuticals Introduction
10.11.4 Sun Revenue in Biopharmaceuticals Business (2018-2023)
10.11.5 Sun Recent Development
10.12 3sbio
10.12.1 3sbio Company Details
10.12.2 3sbio Business Overview
10.12.3 3sbio Biopharmaceuticals Introduction
10.12.4 3sbio Revenue in Biopharmaceuticals Business (2018-2023)
10.12.5 3sbio Recent Development
10.13 Changchun High Tech
10.13.1 Changchun High Tech Company Details
10.13.2 Changchun High Tech Business Overview
10.13.3 Changchun High Tech Biopharmaceuticals Introduction
10.13.4 Changchun High Tech Revenue in Biopharmaceuticals Business (2018-2023)
10.13.5 Changchun High Tech Recent Development
10.14 CP Guojian
10.14.1 CP Guojian Company Details
10.14.2 CP Guojian Business Overview
10.14.3 CP Guojian Biopharmaceuticals Introduction
10.14.4 CP Guojian Revenue in Biopharmaceuticals Business (2018-2023)
10.14.5 CP Guojian Recent Development
10.15 Biotech
10.15.1 Biotech Company Details
10.15.2 Biotech Business Overview
10.15.3 Biotech Biopharmaceuticals Introduction
10.15.4 Biotech Revenue in Biopharmaceuticals Business (2018-2023)
10.15.5 Biotech Recent Development
10.16 Gelgen
10.16.1 Gelgen Company Details
10.16.2 Gelgen Business Overview
10.16.3 Gelgen Biopharmaceuticals Introduction
10.16.4 Gelgen Revenue in Biopharmaceuticals Business (2018-2023)
10.16.5 Gelgen Recent Development
10.17 Innovent
10.17.1 Innovent Company Details
10.17.2 Innovent Business Overview
10.17.3 Innovent Biopharmaceuticals Introduction
10.17.4 Innovent Revenue in Biopharmaceuticals Business (2018-2023)
10.17.5 Innovent Recent Development
10.18 Dong Bao
10.18.1 Dong Bao Company Details
10.18.2 Dong Bao Business Overview
10.18.3 Dong Bao Biopharmaceuticals Introduction
10.18.4 Dong Bao Revenue in Biopharmaceuticals Business (2018-2023)
10.18.5 Dong Bao Recent Development
10.19 Ganlee
10.19.1 Ganlee Company Details
10.19.2 Ganlee Business Overview
10.19.3 Ganlee Biopharmaceuticals Introduction
10.19.4 Ganlee Revenue in Biopharmaceuticals Business (2018-2023)
10.19.5 Ganlee Recent Development
10.20 United Laboratories
10.20.1 United Laboratories Company Details
10.20.2 United Laboratories Business Overview
10.20.3 United Laboratories Biopharmaceuticals Introduction
10.20.4 United Laboratories Revenue in Biopharmaceuticals Business (2018-2023)
10.20.5 United Laboratories Recent Development
10.21 SANDOZ (NOVARTIS)
10.21.1 SANDOZ (NOVARTIS) Company Details
10.21.2 SANDOZ (NOVARTIS) Business Overview
10.21.3 SANDOZ (NOVARTIS) Biopharmaceuticals Introduction
10.21.4 SANDOZ (NOVARTIS) Revenue in Biopharmaceuticals Business (2018-2023)
10.21.5 SANDOZ (NOVARTIS) Recent Development
10.22 Teva Pharmaceutical
10.22.1 Teva Pharmaceutical Company Details
10.22.2 Teva Pharmaceutical Business Overview
10.22.3 Teva Pharmaceutical Biopharmaceuticals Introduction
10.22.4 Teva Pharmaceutical Revenue in Biopharmaceuticals Business (2018-2023)
10.22.5 Teva Pharmaceutical Recent Development
10.23 Hospira （Pfizer）
10.23.1 Hospira （Pfizer） Company Details
10.23.2 Hospira （Pfizer） Business Overview
10.23.3 Hospira （Pfizer） Biopharmaceuticals Introduction
10.23.4 Hospira （Pfizer） Revenue in Biopharmaceuticals Business (2018-2023)
10.23.5 Hospira （Pfizer） Recent Development
10.24 MYLAN
10.24.1 MYLAN Company Details
10.24.2 MYLAN Business Overview
10.24.3 MYLAN Biopharmaceuticals Introduction
10.24.4 MYLAN Revenue in Biopharmaceuticals Business (2018-2023)
10.24.5 MYLAN Recent Development
10.25 Sun pharma
10.25.1 Sun pharma Company Details
10.25.2 Sun pharma Business Overview
10.25.3 Sun pharma Biopharmaceuticals Introduction
10.25.4 Sun pharma Revenue in Biopharmaceuticals Business (2018-2023)
10.25.5 Sun pharma Recent Development
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.2 Data Source
12.2 Disclaimer
12.3 Author Details
FEATURED COMPANIES
Roche
Amgen Inc
AbbVie
Sanofi Aventis
Johnson & Johnson
Pfizer Inc
Novo Nordisk
Eli Lilly
Novartis
Merck
Sun
3SBio Inc
Changchun High Tech
CP Guojian
Biotech
Gelgen
Innovent
Dong Bao
Ganlee
United Laboratories
Sandoz(Novartis)
Teva Pharmaceutical
Hospira (Pfizer)
Mylan NV
Sun Pharma
List of Tables
    Table 1. Biopharmaceuticals Market Size India VS Global, CAGR (2018 VS 2022 VS 2029)
    Table 2. Biopharmaceuticals Market Trends
    Table 3. Biopharmaceuticals Market Drivers
    Table 4. Biopharmaceuticals Market Challenges
    Table 5. Biopharmaceuticals Market Restraints
    Table 6. Global Biopharmaceuticals Market Size by Type: 2018 VS 2022 VS 2029 (US$ Million)
    Table 7. India Biopharmaceuticals Market Size by Type: 2018 VS 2022 VS 2029 (US$ Million)
    Table 8. Global Biopharmaceuticals Market Size by Application: 2018 VS 2022 VS 2029 (US$ Million)
    Table 9. India Biopharmaceuticals Market Size by Application: 2018 VS 2022 VS 2029 (US$ Million)
    Table 10. Global Key Companies of Biopharmaceuticals, Ranked by Revenue (2022) & (US$ Million)
    Table 11. Global Biopharmaceuticals Revenue by Player, (US$ Million), 2018-2023
    Table 12. Global Biopharmaceuticals Revenue Share by Player, 2018-2023
    Table 13. Global Biopharmaceuticals Companies Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Biopharmaceuticals by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biopharmaceuticals as of 2022)
    Table 15. Global Key Players of Biopharmaceuticals, Headquarters and Area Served
    Table 16. Global Key Players of Biopharmaceuticals, Product and Application
    Table 17. Global Key Players of Biopharmaceuticals, Date of Enter into This Industry
    Table 18. Companies Mergers & Acquisitions, Expansion Plans
    Table 19. Key Players of Biopharmaceuticals in India, Ranked by Revenue (2022) & (US$ Million)
    Table 20. India Biopharmaceuticals Revenue by Players, (US$ Million), 2021, 2022 & 2023
    Table 21. India Biopharmaceuticals Revenue Share by Players, 2021, 2022 & 2023
    Table 22. Global Biopharmaceuticals Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 23. Global Biopharmaceuticals Market Size by Region (2018-2023) & (US$ Million)
    Table 24. Global Biopharmaceuticals Market Size Forecast by Region (2024-2029) & (US$ Million)
    Table 25. Americas Biopharmaceuticals Market Size by Type (2018-2023) & (US$ Million)
    Table 26. Americas Biopharmaceuticals Market Size by Type (2024-2029) & (US$ Million)
    Table 27. Americas Biopharmaceuticals Market Size by Application (2018-2023) & (US$ Million)
    Table 28. Americas Biopharmaceuticals Market Size by Application (2024-2029) & (US$ Million)
    Table 29. Americas Biopharmaceuticals Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 30. Americas Biopharmaceuticals Market Size by Country (2018-2023) & (US$ Million)
    Table 31. Americas Biopharmaceuticals Market Size by Country (2024-2029) & (US$ Million)
    Table 32. EMEA Biopharmaceuticals Market Size by Type (2018-2023) & (US$ Million)
    Table 33. EMEA Biopharmaceuticals Market Size by Type (2024-2029) & (US$ Million)
    Table 34. EMEA Biopharmaceuticals Market Size by Application (2018-2023) & (US$ Million)
    Table 35. EMEA Biopharmaceuticals Market Size by Application (2024-2029) & (US$ Million)
    Table 36. EMEA Biopharmaceuticals Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 37. EMEA Biopharmaceuticals Market Size by Country (2018-2023) & (US$ Million)
    Table 38. EMEA Biopharmaceuticals Market Size by Country (2024-2029) & (US$ Million)
    Table 39. China Biopharmaceuticals Market Size by Type (2018-2023) & (US$ Million)
    Table 40. China Biopharmaceuticals Market Size by Type (2024-2029) & (US$ Million)
    Table 41. China Biopharmaceuticals Market Size by Application (2018-2023) & (US$ Million)
    Table 42. China Biopharmaceuticals Market Size by Application (2024-2029) & (US$ Million)
    Table 43. China Biopharmaceuticals Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 44. APAC Biopharmaceuticals Market Size by Type (2018-2023) & (US$ Million)
    Table 45. APAC Biopharmaceuticals Market Size by Type (2024-2029) & (US$ Million)
    Table 46. APAC Biopharmaceuticals Market Size by Application (2018-2023) & (US$ Million)
    Table 47. APAC Biopharmaceuticals Market Size by Application (2024-2029) & (US$ Million)
    Table 48. APAC Biopharmaceuticals Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 49. APAC Biopharmaceuticals Market Size by Region (2018-2023) & (US$ Million)
    Table 50. APAC Biopharmaceuticals Market Size by Region (2024-2029) & (US$ Million)
    Table 51. Roche Company Details
    Table 52. Roche Business Overview
    Table 53. Roche Biopharmaceuticals Product
    Table 54. Roche Revenue in Biopharmaceuticals Business (2018-2023) & (US$ Million)
    Table 55. Roche Recent Development
    Table 56. Amgen Company Details
    Table 57. Amgen Business Overview
    Table 58. Amgen Biopharmaceuticals Product
    Table 59. Amgen Revenue in Biopharmaceuticals Business (2018-2023) & (US$ Million)
    Table 60. Amgen Recent Development
    Table 61. AbbVie Company Details
    Table 62. AbbVie Business Overview
    Table 63. AbbVie Biopharmaceuticals Product
    Table 64. AbbVie Revenue in Biopharmaceuticals Business (2018-2023) & (US$ Million)
    Table 65. AbbVie Recent Development
    Table 66. Sanofi-Aventis Company Details
    Table 67. Sanofi-Aventis Business Overview
    Table 68. Sanofi-Aventis Biopharmaceuticals Product
    Table 69. Sanofi-Aventis Revenue in Biopharmaceuticals Business (2018-2023) & (US$ Million)
    Table 70. Sanofi-Aventis Recent Development
    Table 71. Johnson & Johnson Company Details
    Table 72. Johnson & Johnson Business Overview
    Table 73. Johnson & Johnson Biopharmaceuticals Product
    Table 74. Johnson & Johnson Revenue in Biopharmaceuticals Business (2018-2023) & (US$ Million)
    Table 75. Johnson & Johnson Recent Development
    Table 76. Pfizer Company Details
    Table 77. Pfizer Business Overview
    Table 78. Pfizer Biopharmaceuticals Product
    Table 79. Pfizer Revenue in Biopharmaceuticals Business (2018-2023) & (US$ Million)
    Table 80. Pfizer Recent Development
    Table 81. Novo Nordisk Company Details
    Table 82. Novo Nordisk Business Overview
    Table 83. Novo Nordisk Biopharmaceuticals Product
    Table 84. Novo Nordisk Revenue in Biopharmaceuticals Business (2018-2023) & (US$ Million)
    Table 85. Novo Nordisk Recent Development
    Table 86. Eli Lilly Company Details
    Table 87. Eli Lilly Business Overview
    Table 88. Eli Lilly Biopharmaceuticals Product
    Table 89. Eli Lilly Revenue in Biopharmaceuticals Business (2018-2023) & (US$ Million)
    Table 90. Eli Lilly Recent Development
    Table 91. Novartis Company Details
    Table 92. Novartis Business Overview
    Table 93. Novartis Biopharmaceuticals Product
    Table 94. Novartis Revenue in Biopharmaceuticals Business (2018-2023) & (US$ Million)
    Table 95. Novartis Recent Development
    Table 96. Merck Company Details
    Table 97. Merck Business Overview
    Table 98. Merck Biopharmaceuticals Product
    Table 99. Merck Revenue in Biopharmaceuticals Business (2018-2023) & (US$ Million)
    Table 100. Merck Recent Development
    Table 101. Sun Company Details
    Table 102. Sun Business Overview
    Table 103. Sun Biopharmaceuticals Product
    Table 104. Sun Revenue in Biopharmaceuticals Business (2018-2023) & (US$ Million)
    Table 105. Sun Recent Development
    Table 106. 3sbio Company Details
    Table 107. 3sbio Business Overview
    Table 108. 3sbio Biopharmaceuticals Product
    Table 109. 3sbio Revenue in Biopharmaceuticals Business (2018-2023) & (US$ Million)
    Table 110. 3sbio Recent Development
    Table 111. Changchun High Tech Company Details
    Table 112. Changchun High Tech Business Overview
    Table 113. Changchun High Tech Biopharmaceuticals Product
    Table 114. Changchun High Tech Revenue in Biopharmaceuticals Business (2018-2023) & (US$ Million)
    Table 115. Changchun High Tech Recent Development
    Table 116. CP Guojian Company Details
    Table 117. CP Guojian Business Overview
    Table 118. CP Guojian Biopharmaceuticals Product
    Table 119. CP Guojian Revenue in Biopharmaceuticals Business (2018-2023) & (US$ Million)
    Table 120. CP Guojian Recent Development
    Table 121. Biotech Company Details
    Table 122. Biotech Business Overview
    Table 123. Biotech Biopharmaceuticals Product
    Table 124. Biotech Revenue in Biopharmaceuticals Business (2018-2023) & (US$ Million)
    Table 125. Biotech Recent Development
    Table 126. Gelgen Company Details
    Table 127. Gelgen Business Overview
    Table 128. Gelgen Biopharmaceuticals Product
    Table 129. Gelgen Revenue in Biopharmaceuticals Business (2018-2023) & (US$ Million)
    Table 130. Gelgen Recent Development
    Table 131. Innovent Company Details
    Table 132. Innovent Business Overview
    Table 133. Innovent Biopharmaceuticals Product
    Table 134. Innovent Revenue in Biopharmaceuticals Business (2018-2023) & (US$ Million)
    Table 135. Innovent Recent Development
    Table 136. Dong Bao Company Details
    Table 137. Dong Bao Business Overview
    Table 138. Dong Bao Biopharmaceuticals Product
    Table 139. Dong Bao Revenue in Biopharmaceuticals Business (2018-2023) & (US$ Million)
    Table 140. Dong Bao Recent Development
    Table 141. Ganlee Company Details
    Table 142. Ganlee Business Overview
    Table 143. Ganlee Biopharmaceuticals Product
    Table 144. Ganlee Revenue in Biopharmaceuticals Business (2018-2023) & (US$ Million)
    Table 145. Ganlee Recent Development
    Table 146. United Laboratories Company Details
    Table 147. United Laboratories Business Overview
    Table 148. United Laboratories Biopharmaceuticals Product
    Table 149. United Laboratories Revenue in Biopharmaceuticals Business (2018-2023) & (US$ Million)
    Table 150. United Laboratories Recent Development
    Table 151. SANDOZ (NOVARTIS) Company Details
    Table 152. SANDOZ (NOVARTIS) Business Overview
    Table 153. SANDOZ (NOVARTIS) Biopharmaceuticals Product
    Table 154. SANDOZ (NOVARTIS) Revenue in Biopharmaceuticals Business (2018-2023) & (US$ Million)
    Table 155. SANDOZ (NOVARTIS) Recent Development
    Table 156. Teva Pharmaceutical Company Details
    Table 157. Teva Pharmaceutical Business Overview
    Table 158. Teva Pharmaceutical Biopharmaceuticals Product
    Table 159. Teva Pharmaceutical Revenue in Biopharmaceuticals Business (2018-2023) & (US$ Million)
    Table 160. Teva Pharmaceutical Recent Development
    Table 161. Hospira （Pfizer） Company Details
    Table 162. Hospira （Pfizer） Business Overview
    Table 163. Hospira （Pfizer） Biopharmaceuticals Product
    Table 164. Hospira （Pfizer） Revenue in Biopharmaceuticals Business (2018-2023) & (US$ Million)
    Table 165. Hospira （Pfizer） Recent Development
    Table 166. MYLAN Company Details
    Table 167. MYLAN Business Overview
    Table 168. MYLAN Biopharmaceuticals Product
    Table 169. MYLAN Revenue in Biopharmaceuticals Business (2018-2023) & (US$ Million)
    Table 170. MYLAN Recent Development
    Table 171. Sun pharma Company Details
    Table 172. Sun pharma Business Overview
    Table 173. Sun pharma Biopharmaceuticals Product
    Table 174. Sun pharma Revenue in Biopharmaceuticals Business (2018-2023) & (US$ Million)
    Table 175. Sun pharma Recent Development
    Table 176. Research Programs/Design for This Report
    Table 177. Key Data Information from Secondary Sources
    Table 178. Key Data Information from Primary Sources
List of Figures
    Figure 1. Biopharmaceuticals Product Picture
    Figure 2. Global Biopharmaceuticals Market Size, (US$ Million), 2018 VS 2022 VS 2029
    Figure 3. Global Biopharmaceuticals Market Size 2018-2029 (US$ Million)
    Figure 4. India Biopharmaceuticals Market Size, (US$ Million), 2018 VS 2022 VS 2029
    Figure 5. India Biopharmaceuticals Market Size 2018-2029 (US$ Million)
    Figure 6. India Biopharmaceuticals Market Share in Global 2018-2029
    Figure 7. Biopharmaceuticals Report Years Considered
    Figure 8. Product Picture of Monoclonal Antibodies
    Figure 9. Product Picture of Interferon
    Figure 10. Product Picture of Colony-Stimulating Factor
    Figure 11. Product Picture of Erythropoietin
    Figure 12. Product Picture of Insulin
    Figure 13. Product Picture of Vaccines
    Figure 14. Product Picture of Growth Hormones
    Figure 15. Product Picture of Others
    Figure 16. Global Biopharmaceuticals Market Share by Type in 2022 & 2029
    Figure 17. Global Biopharmaceuticals Market Size by Type (2018-2029) & (US$ Million)
    Figure 18. Global Biopharmaceuticals Market Share by Type (2018-2029)
    Figure 19. India Biopharmaceuticals Market Share by Type in 2022 & 2029
    Figure 20. India Biopharmaceuticals Market Size by Type (2018-2029) & (US$ Million)
    Figure 21. India Biopharmaceuticals Market Share by Type (2018-2029)
    Figure 22. Product Picture of Tumor
    Figure 23. Product Picture of Diabetes
    Figure 24. Product Picture of Cardiovascular
    Figure 25. Product Picture of Hemophilia
    Figure 26. Product Picture of Others
    Figure 27. Global Biopharmaceuticals Market Share by Application in 2022 & 2029
    Figure 28. Global Biopharmaceuticals Market Size by Application (2018-2029) & (US$ Million)
    Figure 29. Global Biopharmaceuticals Market Share by Application (2018-2029)
    Figure 30. India Biopharmaceuticals Market Share by Application in 2022 & 2029
    Figure 31. India Biopharmaceuticals Market Size by Application (2018-2029) & (US$ Million)
    Figure 32. India Biopharmaceuticals Market Share by Application (2018-2029)
    Figure 33. The Top 5 and 10 Largest Companies of Biopharmaceuticals in the World: Market Share by Biopharmaceuticals Revenue in 2022
    Figure 34. Global Biopharmaceuticals Market Size Market Share by Region: 2018 VS 2022 VS 2029
    Figure 35. Global Biopharmaceuticals Market Share by Region (2018-2029)
    Figure 36. Americas Biopharmaceuticals Market Size Growth Rate 2018-2029 (US$ Million)
    Figure 37. Americas Biopharmaceuticals Market Share by Type (2018-2029)
    Figure 38. Americas Biopharmaceuticals Market Share by Application (2018-2029)
    Figure 39. United States Biopharmaceuticals Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 40. Canada Biopharmaceuticals Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 41. Mexico Biopharmaceuticals Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 42. Brazil Biopharmaceuticals Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 43. EMEA Biopharmaceuticals Market Size Growth Rate 2018-2029 (US$ Million)
    Figure 44. EMEA Biopharmaceuticals Market Share by Type (2018-2029)
    Figure 45. EMEA Biopharmaceuticals Market Share by Application (2018-2029)
    Figure 46. Europe Biopharmaceuticals Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 47. Middle East Biopharmaceuticals Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 48. Africa Biopharmaceuticals Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 49. China Biopharmaceuticals Market Size Growth Rate 2018-2029 (US$ Million)
    Figure 50. China Biopharmaceuticals Market Share by Type (2018-2029)
    Figure 51. China Biopharmaceuticals Market Share by Application (2018-2029)
    Figure 52. APAC Biopharmaceuticals Market Size Growth Rate 2018-2029 (US$ Million)
    Figure 53. APAC Biopharmaceuticals Market Share by Type (2018-2029)
    Figure 54. APAC Biopharmaceuticals Market Share by Application (2018-2029)
    Figure 55. Japan Biopharmaceuticals Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 56. South Korea Biopharmaceuticals Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 57. China Taiwan Biopharmaceuticals Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 58. Southeast Asia Biopharmaceuticals Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 59. India Biopharmaceuticals Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 60. Roche Revenue Growth Rate in Biopharmaceuticals Business (2018-2023)
    Figure 61. Amgen Revenue Growth Rate in Biopharmaceuticals Business (2018-2023)
    Figure 62. AbbVie Revenue Growth Rate in Biopharmaceuticals Business (2018-2023)
    Figure 63. Sanofi-Aventis Revenue Growth Rate in Biopharmaceuticals Business (2018-2023)
    Figure 64. Johnson & Johnson Revenue Growth Rate in Biopharmaceuticals Business (2018-2023)
    Figure 65. Pfizer Revenue Growth Rate in Biopharmaceuticals Business (2018-2023)
    Figure 66. Novo Nordisk Revenue Growth Rate in Biopharmaceuticals Business (2018-2023)
    Figure 67. Eli Lilly Revenue Growth Rate in Biopharmaceuticals Business (2018-2023)
    Figure 68. Novartis Revenue Growth Rate in Biopharmaceuticals Business (2018-2023)
    Figure 69. Merck Revenue Growth Rate in Biopharmaceuticals Business (2018-2023)
    Figure 70. Sun Revenue Growth Rate in Biopharmaceuticals Business (2018-2023)
    Figure 71. 3sbio Revenue Growth Rate in Biopharmaceuticals Business (2018-2023)
    Figure 72. Changchun High Tech Revenue Growth Rate in Biopharmaceuticals Business (2018-2023)
    Figure 73. CP Guojian Revenue Growth Rate in Biopharmaceuticals Business (2018-2023)
    Figure 74. Biotech Revenue Growth Rate in Biopharmaceuticals Business (2018-2023)
    Figure 75. Gelgen Revenue Growth Rate in Biopharmaceuticals Business (2018-2023)
    Figure 76. Innovent Revenue Growth Rate in Biopharmaceuticals Business (2018-2023)
    Figure 77. Dong Bao Revenue Growth Rate in Biopharmaceuticals Business (2018-2023)
    Figure 78. Ganlee Revenue Growth Rate in Biopharmaceuticals Business (2018-2023)
    Figure 79. United Laboratories Revenue Growth Rate in Biopharmaceuticals Business (2018-2023)
    Figure 80. SANDOZ (NOVARTIS) Revenue Growth Rate in Biopharmaceuticals Business (2018-2023)
    Figure 81. Teva Pharmaceutical Revenue Growth Rate in Biopharmaceuticals Business (2018-2023)
    Figure 82. Hospira （Pfizer） Revenue Growth Rate in Biopharmaceuticals Business (2018-2023)
    Figure 83. MYLAN Revenue Growth Rate in Biopharmaceuticals Business (2018-2023)
    Figure 84. Sun pharma Revenue Growth Rate in Biopharmaceuticals Business (2018-2023)
    Figure 85. Bottom-up and Top-down Approaches for This Report
    Figure 86. Data Triangulation
    Figure 87. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4350

This license allows only one user to access the PDF.
Electronic (PDF)

$6525

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$8700

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Lukasiewicz Research Network

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Pharmacy Chatbot Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-10T20319
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Inline Pharmaceutical Packaging Leak Detection System Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-6Q20319
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Radiological Marker Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-35Z19949
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Pharmaceutical Biomanufacturing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-26E19785
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions